These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4686516)
21. Renal failure associated with the use of dextran-40. Zwaveling JH; Meulenbelt J; van Xanten NH; Hené RJ Neth J Med; 1989 Dec; 35(5-6):321-6. PubMed ID: 2483959 [TBL] [Abstract][Full Text] [Related]
22. Renal toxicity of low molecular weight dextran: a review of the literature. Figueroa JE; Burgos-Calderon R J La State Med Soc; 1974 Dec; 126(12):425-7. PubMed ID: 4436605 [No Abstract] [Full Text] [Related]
23. [Acute renal failure caused by dextran of low molecular weight]. Alvarez Grande H; Oliva Aldámiz H; López de Novales E; Barrientos Guzmán A; Hernando Avendaño L Rev Clin Esp; 1970 Jan; 116(2):169-72. PubMed ID: 5453847 [No Abstract] [Full Text] [Related]
24. [Dextran of low molecular weight in peripheral arterial insufficiency]. Amoroso A; Guadagno L; Pozzi LL Omnia Med Ther; 1965; 43(1):151-67. PubMed ID: 5824979 [No Abstract] [Full Text] [Related]
25. Acute renal failure during dextran-40 antithrombotic prophylaxis: report of two microsurgical cases. Vos SC; Hage JJ; Woerdeman LA; Noordanus R Ann Plast Surg; 2002 Feb; 48(2):193-6. PubMed ID: 11910227 [TBL] [Abstract][Full Text] [Related]
26. [Experimental kidney damage produced by the combined use of low molecular weight dextran and antibiotics]. Ueda T Nihon Jinzo Gakkai Shi; 1974 Jun; 16(6):629-56. PubMed ID: 4478698 [No Abstract] [Full Text] [Related]
27. [Experimental study of acute ischemia of the limbs. 3]. Stipa S; Cavallaro A; Bolognese A Chir Patol Sper; 1968 Dec; 16(6):553-626. PubMed ID: 5740720 [No Abstract] [Full Text] [Related]
28. [On the effectiveness of combined therapy with a polysulpho-ester of xylan (Fibrase) and dextran (Macrodex) in vascular occlusions of the retina]. Cambiaggi A; Magnasco A; Sanna G Ann Ottalmol Clin Ocul; 1968 Apr; 94(4):349-55. PubMed ID: 5708189 [No Abstract] [Full Text] [Related]
29. [Study of the association of dextran, potassium-sulfate and pyridinol-carbamate in vascular diseases and dyslipemias]. Padros W Angiologia; 1972; 24(4):139-42. PubMed ID: 5050115 [No Abstract] [Full Text] [Related]
30. [Death caused by infusion of low-molecular dextran]. Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858 [No Abstract] [Full Text] [Related]
31. The influence of low molecular weight dextran on occlusive vascular disease. Fry WJ; Parker GW Surg Gynecol Obstet; 1966 Sep; 123(3):531-4. PubMed ID: 5912865 [No Abstract] [Full Text] [Related]
32. [Complications due to injection of high-molecular-weight dextran during the study of the survival in vitro of labelled granulocytes]. Dresch C; Hurez D; Basch A; Najean Y Nouv Rev Fr Hematol; 1970; 10(2):277-84. PubMed ID: 4246280 [No Abstract] [Full Text] [Related]
33. [Side-effects in patients treated with dextran]. Kowal-Gierczak B; Janukowicz-Lorenz H Wiad Lek; 1974 Feb; 27(4):341-5. PubMed ID: 4130922 [No Abstract] [Full Text] [Related]
34. Efficacy of dextran solutions in vascular surgery. Abir F; Barkhordarian S; Sumpio BE Vasc Endovascular Surg; 2004; 38(6):483-91. PubMed ID: 15592628 [TBL] [Abstract][Full Text] [Related]
35. Low molecular weight dextran: a continuing cause of acute renal failure. Feest TG Br Med J; 1976 Nov; 2(6047):1300. PubMed ID: 1000202 [No Abstract] [Full Text] [Related]
36. [The dextran of low molecular weight in the treatment of vascular retinal complications]. Thomas C; Reny A; Raspiller A Bull Soc Ophtalmol Fr; 1967 Dec; 67(12):1163-5. PubMed ID: 5621637 [No Abstract] [Full Text] [Related]